The VALIDATE Network - Vaccine development for complex intracellular neglected pathogens
MRC Infections & Immunity Board Research Grants, 2020
Call opens: 20 Jul 2020
Deadline for applications: 16 Sep 2020 16:00 (UK+1)
MRC research grants are suitable for focused research projects that may be short- or long-term in nature. In addition, they can be used to support method development or development and continuation of research facilities and may involve more than one research group or institution. A research grant can be awarded for any period of up to five years, but those of two years or less are for proof of principle or pilot work only. Research grants do not cover programmatic approaches or research involving randomised trials of clinical treatments.The budget for research grant awards will not typically exceed £1 million.
The Infections and Immunity Board (IIB) funds research into infectious human disease and disorders of the human immune system. This is underpinned by fundamental research into human pathogens, as well as the normal development and functioning of the human immune system. They fund basic, clinical and translational research into pathogens implicated in human infectious diseases. This includes understanding of the pathogen at the molecular and cellular level through to host pathogen interactions and into epidemiology of infectious diseases. They are also keen to fund research to inform novel strategies for preventing and controlling infectious and immune disease control, including research on human behaviour and lifestyle.
Who can apply?
Any UK-based researcher who can demonstrate that they will direct the proposed research and be actively engaged in carrying it through. The minimum academic qualification required is a graduate degree, although usually a PhD is required. Less experienced researchers should apply in collaboration with a more senior colleague. Applications can include an industry partner(s).
For the full call text please visit the MRC grant call webpage.